Tubulin Detyrosination: An Emerging Therapeutic Target in Hypertrophic Cardiomyopathy.
Margulies KB, Prosser BL.
Circ Heart Fail. 2021 Jan;14(1):e008006. Epub 2021 Jan 12. PMID: 33430601. doi: 10.1161/CIRCHEARTFAILURE.120.008006.